Overview of Regenerative Medicine Therapies

Platelet-Rich Plasma (PRP)

Platelet-Rich Plasma is produced by drawing a person’s blood and separating it in a centrifuge to concentrate platelets. PRP contains a high level of platelets along with plasma proteins and growth factors. These growth factors (e.g., PDGF, TGF-β, VEGF, IGF-1) play important roles in cell growth, tissue repair, angiogenesis (new blood vessel formation), and reducing inflammation. It is prepared in various formulations depending on platelet concentration and whether white blood cells or fibrin are included.

Wharton’s Jelly Matrix

Wharton’s Jelly is a gelatinous connective tissue found within the umbilical cord. It surrounds the umbilical vessels and contains extracellular matrix components such as collagen, glycosaminoglycans, and hyaluronic acid. The matrix also provides structural support and contains mesenchymal stromal cells and signaling proteins.

Umbilical Cord–Derived Stem Cells (UC-MSCs)

Umbilical cord tissue is a source of mesenchymal stem/stromal cells (MSCs), which are multipotent cells capable of differentiating into various cell types in laboratory conditions. UC-MSCs are isolated from Wharton’s Jelly, the umbilical cord lining, or cord blood, and are valued in research because of their proliferative capacity and relatively low immunogenicity.

Amniotic Fluid–Derived Exosomes

Amniotic fluid contains extracellular vesicles, including exosomes—small, membrane-bound particles released by cells. These vesicles carry proteins, lipids, and nucleic acids, serving as a communication system between cells. Exosomes from amniotic fluid are isolated through specialized laboratory techniques for use in experimental and clinical research.

Summary: These regenerative medicine products—PRP, Wharton’s Jelly matrix, umbilical cord–derived stem cells, and amniotic fluid–derived exosomes—represent distinct biologic materials, each with unique origins, cellular components, and molecular properties.